Treatment Options for a 38-Year-Old Woman with FSH 7 and LH 15
A 38-year-old woman with FSH of 7 and LH of 15 likely has polycystic ovary syndrome (PCOS) and should be referred to a reproductive endocrinologist for fertility evaluation and treatment with appropriate ovulation induction therapy. 1
Hormonal Profile Interpretation
- LH:FSH Ratio: At 15:7 (>2:1), this ratio strongly suggests PCOS as the underlying diagnosis 1
- Normal FSH levels (typically 3-10 IU/L in reproductive years) with elevated LH is a classic pattern in PCOS
- This pattern differs from:
- Premature ovarian insufficiency (which would show elevated FSH >40 IU/L)
- Hypothalamic amenorrhea (which would show low/normal LH and FSH)
Recommended Evaluation
Complete hormonal assessment:
- Testosterone and free testosterone (to confirm hyperandrogenism)
- Estradiol (to assess estrogen production)
- Prolactin (to rule out hyperprolactinemia)
- TSH (to exclude thyroid dysfunction)
Ultrasound evaluation:
- Transvaginal ultrasound to assess ovarian morphology
- Look for polycystic ovaries (≥12 follicles measuring 2-9mm in diameter)
- Evaluate endometrial thickness
Metabolic screening:
- Glucose tolerance test
- Lipid profile
- Blood pressure assessment
Treatment Options
First-line treatments:
Lifestyle modifications:
- Weight loss (if BMI >25)
- Regular exercise
- Balanced diet
Ovulation induction:
- Clomiphene citrate: First-line pharmacological treatment
- Letrozole: Alternative first-line agent, particularly effective in PCOS
Metformin:
- Consider for patients with insulin resistance
- May improve ovulation rates when combined with clomiphene
Second-line treatments:
Gonadotropin therapy:
- Low-dose FSH protocols to prevent ovarian hyperstimulation
- Careful monitoring with ultrasound and estradiol levels
- May require dose adjustments based on response 2
Laparoscopic ovarian drilling:
- Consider for clomiphene-resistant PCOS
- Can restore ovulation in 70-80% of cases
Advanced reproductive technologies:
- In vitro fertilization (IVF):
- Recommended if other treatments fail
- May use GnRH antagonist protocols to prevent OHSS
- Careful monitoring due to risk of hyperstimulation
Important Considerations
- Age factor: At 38, fertility is declining naturally, making timely intervention crucial
- OHSS risk: Women with PCOS have higher risk of ovarian hyperstimulation syndrome
- Multiple pregnancy risk: Increased with ovulation induction therapies
- Monitoring: Regular follicular monitoring with ultrasound is essential during treatment
Cautions and Pitfalls
- Avoid testosterone therapy as it would further disrupt the hormonal balance and impair fertility 3
- The benefits of supplements and antioxidants are questionable for treating fertility issues 3
- Be cautious with high-dose gonadotropin therapy due to risk of hyperstimulation in PCOS patients
- Monitor for metabolic complications common in PCOS (diabetes, hypertension, dyslipidemia)
Follow-up Recommendations
- Reassess hormonal profile after 3 months of initial therapy
- If no response to first-line treatment after 3-6 cycles, progress to second-line options
- Consider IVF earlier rather than later given the patient's age and the time-sensitive nature of fertility treatment